Infographic

Nov, 27 2023

Middle East and Africa Hereditary Transthyretin Amyloidosis Market is Expected to Register a Healthy CAGR in the Forecast Period of 2023 to 2030

Middle East and Africa Hereditary Transthyretin Amyloidosis Market, By Diagnosis and Treatment (Diagnosis and Treatment), Gene Variation (V122L, T60A, V30M, and Others), Gender (Male and Female), Indication (Cardiomyopathy (ATTR-CM), Polyneuropathy (ATTR-PN), and Mixed Indications), End User (Hospitals and Clinics, Diagnostic Laboratories, Radiology Centers, Academic and Research Institutes, Ambulatory Surgical Centers, and Homecare), Distribution Channel (Direct Tender, Third Party Distributors, Hospital Pharmacy, Retail Pharmacy, and Others) - Industry Trends and Forecast to 2030.

Access Full Report @ https://www.databridgemarketresearch.com/reports/middle-east-and-africa-hereditary-transthyretin-amyloidosis-market

Middle East and Africa Hereditary Transthyretin Amyloidosis Market

Data Bridge Market Research

Office Number 402, Amanora Chambers, Magarpatta Road,

Hadapsar Pune – 411028.

Email: sales@databridgemarketresearch.com

Blog @ https://www.databridgemarketresearch.com/news


Client Testimonials